AP NEWS
Related topics

Regulus: 2Q Earnings Snapshot

August 9, 2018

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $13.8 million in its second quarter.

The San Diego-based company said it had a loss of 13 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The biopharmaceutical company posted revenue of $18,000 in the period.

In the final minutes of trading on Thursday, the company’s shares hit 22 cents. A year ago, they were trading at 90 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS

AP RADIO
Update hourly